Search

everythinglearnresearchcommunity

for

Search:↓

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Research on transgender men needs clearer theories to improve understanding and decision-making.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.